Loading clinical trials...
Loading clinical trials...
An Open-label, Long-term, Prospective, Observational Study to Monitor the Safety and Effectiveness of Ilaris in CAPS Patients
The purpose of this observational study is to collect additional information regarding long-term safety and effectiveness of Ilaris in the treatment of CAPS patients in clinical practice.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Little Rock Allergy and Asthma Clinic
Little Rock, Arizona, United States
Allergy Center at Brookstone
Columbus, Georgia, United States
Rush Presbyterian - St. Lukes Medical Center
Chicago, Illinois, United States
Novartis Investigative site
Bregenz, Austria
Novartis Investigative site
Vienna, Austria
Novartis Investigative site
Dresden, Germany
Novartis Investigative site
Hamburg, Germany
Novartis Investigative site
Heidelberg, Germany
Novartis Investigative site
Herne, Germany
Novartis Investigative site
Kiel, Germany
Start Date
November 1, 2009
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
March 28, 2016
288
ACTUAL participants
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions